114 related articles for article (PubMed ID: 24983395)
1. Epigenetics of pituitary tumours: an update.
Farrell WE
Curr Opin Endocrinol Diabetes Obes; 2014 Aug; 21(4):299-305. PubMed ID: 24983395
[TBL] [Abstract][Full Text] [Related]
2. Epigenomic silencing of the BMP-4 gene in pituitary adenomas: a potential target for epidrug-induced re-expression.
Yacqub-Usman K; Duong CV; Clayton RN; Farrell WE
Endocrinology; 2012 Aug; 153(8):3603-12. PubMed ID: 22700770
[TBL] [Abstract][Full Text] [Related]
3. The EFEMP1 gene: a frequent target for epigenetic silencing in multiple human pituitary adenoma subtypes.
Duong CV; Yacqub-Usman K; Emes RD; Clayton RN; Farrell WE
Neuroendocrinology; 2013; 98(3):200-11. PubMed ID: 24080855
[TBL] [Abstract][Full Text] [Related]
4. Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells.
Kitchen MO; Yacqub-Usman K; Emes RD; Richardson A; Clayton RN; Farrell WE
Pituitary; 2015 Oct; 18(5):674-84. PubMed ID: 25557289
[TBL] [Abstract][Full Text] [Related]
5. Pituitary tumours: all silent on the epigenetics front.
Dudley KJ; Revill K; Clayton RN; Farrell WE
J Mol Endocrinol; 2009 Jun; 42(6):461-8. PubMed ID: 19208779
[TBL] [Abstract][Full Text] [Related]
6. Preincubation of pituitary tumor cells with the epidrugs zebularine and trichostatin A are permissive for retinoic acid-augmented expression of the BMP-4 and D2R genes.
Yacqub-Usman K; Duong CV; Clayton RN; Farrell WE
Endocrinology; 2013 May; 154(5):1711-21. PubMed ID: 23539512
[TBL] [Abstract][Full Text] [Related]
7. Loss of expression of the growth inhibitory gene GADD45gamma, in human pituitary adenomas, is associated with CpG island methylation.
Bahar A; Bicknell JE; Simpson DJ; Clayton RN; Farrell WE
Oncogene; 2004 Jan; 23(4):936-44. PubMed ID: 14647444
[TBL] [Abstract][Full Text] [Related]
8. Quantitative, genome-wide analysis of the DNA methylome in sporadic pituitary adenomas.
Duong CV; Emes RD; Wessely F; Yacqub-Usman K; Clayton RN; Farrell WE
Endocr Relat Cancer; 2012 Dec; 19(6):805-16. PubMed ID: 23045325
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic mechanisms of tumorigenesis.
Farrell WE
Horm Metab Res; 2005 Jun; 37(6):361-8. PubMed ID: 16001328
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of a novel pituitary tumor apoptosis gene.
Bahar A; Simpson DJ; Cutty SJ; Bicknell JE; Hoban PR; Holley S; Mourtada-Maarabouni M; Williams GT; Clayton RN; Farrell WE
Mol Endocrinol; 2004 Jul; 18(7):1827-39. PubMed ID: 15105437
[TBL] [Abstract][Full Text] [Related]
11. Promoter CpG methylation of multiple genes in pituitary adenomas: frequent involvement of caspase-8.
Bello MJ; De Campos JM; Isla A; Casartelli C; Rey JA
Oncol Rep; 2006 Feb; 15(2):443-8. PubMed ID: 16391867
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide analysis in a murine Dnmt1 knockdown model identifies epigenetically silenced genes in primary human pituitary tumors.
Dudley KJ; Revill K; Whitby P; Clayton RN; Farrell WE
Mol Cancer Res; 2008 Oct; 6(10):1567-74. PubMed ID: 18922972
[TBL] [Abstract][Full Text] [Related]
13. Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island.
Simpson DJ; Hibberts NA; McNicol AM; Clayton RN; Farrell WE
Cancer Res; 2000 Mar; 60(5):1211-6. PubMed ID: 10728677
[TBL] [Abstract][Full Text] [Related]
14. Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma.
Revill K; Dudley KJ; Clayton RN; McNicol AM; Farrell WE
Endocr Relat Cancer; 2009 Jun; 16(2):537-48. PubMed ID: 19218280
[TBL] [Abstract][Full Text] [Related]
15. A novel apoptosis gene identified in the pituitary gland.
Farrell WE
Neuroendocrinology; 2006; 84(4):217-21. PubMed ID: 17135715
[TBL] [Abstract][Full Text] [Related]
16. Histone acetylation patterns of typical and atypical pituitary adenomas indicate epigenetic shift of these tumours.
Ebrahimi A; Schittenhelm J; Honegger J; Schluesener HJ
J Neuroendocrinol; 2011 Jun; 23(6):525-30. PubMed ID: 21453398
[TBL] [Abstract][Full Text] [Related]
17. CDKN2A/p16 inactivation is related to pituitary adenoma type and size.
Seemann N; Kuhn D; Wrocklage C; Keyvani K; Hackl W; Buchfelder M; Fahlbusch R; Paulus W
J Pathol; 2001 Apr; 193(4):491-7. PubMed ID: 11276008
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic change in pituitary tumorigenesis.
Farrell WE; Clayton RN
Endocr Relat Cancer; 2003 Jun; 10(2):323-30. PubMed ID: 12790793
[TBL] [Abstract][Full Text] [Related]
19. Preferential loss of Death Associated Protein kinase expression in invasive pituitary tumours is associated with either CpG island methylation or homozygous deletion.
Simpson DJ; Clayton RN; Farrell WE
Oncogene; 2002 Feb; 21(8):1217-24. PubMed ID: 11850841
[TBL] [Abstract][Full Text] [Related]
20. Effects of DNA methylation on galectin-3 expression in pituitary tumors.
Ruebel KH; Jin L; Qian X; Scheithauer BW; Kovacs K; Nakamura N; Zhang H; Raz A; Lloyd RV
Cancer Res; 2005 Feb; 65(4):1136-40. PubMed ID: 15734994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
